Key result
Biventricular electromechanical model successfully reproduces healthy physiological biomarkers, achieving 51% LVEF.
Why the study?
A comprehensive evaluation of cardiac electromechanical models at cellular, tissue, and organ levels addressing both ECG and pressure-volume biomarkers had not yet been performed to build credibility for clinical applications.
A multi-scale calibration and validation strategy for cardiac electromechanical digital twins successfully reproduced healthy physiological biomarkers, establishing a foundation for their credible use in clinical research.
Supports cardiac digital twin development; leaves open prospective validation before clinical translation.
State-of-the-art cardiac electromechanical modelling and simulation form the basis for recent developments in cardiac Digital Twin technologies. However, a comprehensive evaluation of electromechanical models at cellular, tissue, and organ level has yet to be performed that addresses both ECG and pressure-volume biomarkers. Such an evaluation would build credibility for applications of cardiac Digital Twins in clinical research and therapy development. We aimed to follow ASME V&V40 standards to develop a strategy for calibration, validation, and uncertainty quantification of ventricular electromechanical Digital Twins under healthy conditions. We performed a multi-scaled review of ventricular electromechanics to compile a dataset for calibration and validation incorporating ECG, pressure-volume, displacement, and strain biomarkers. When applied to a biventricular multiscale model, we achieved healthy calibrated values for the QRS duration (89 ms), QT interval (360 ms), left ventricular ejection fraction (LVEF) (51 %), peak systolic pressure (14 kPa), end diastolic (110 mL) and end systolic volumes (50 mL), peak ejection flow rate (180 mL/ms). Model validation was performed by comparison to displacement and strain biomarkers including systolic atrioventricular plane displacement (1.5 cm), systolic fibre strain (−0.18) and longitudinal strain (−0.15). Sensitivity analysis of model parameters at cellular and ventricular scales was also performed. We quantified the effects of variability in ionic conductance, mechanical stiffness, cross-bridge cycling dynamics, and systemic circulation on action potential and active tension dynamics at the cellular scale, and on ECG, pressure-volume, displacement, and strain biomarkers at the ventricular scale. Simulations showed that the relationship between healthy LVEF and T wave biomarkers was primarily underpinned by variability in L-type calcium channel conductance and SERCA activity through multi-scale effects. In this study, we pave the way towards credible cardiac electromechanical Digital Twins by setting the basis for a strategy for calibration and validation based on both ECG and mechanical biomarkers.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied Healthy cardiac electromechanics (n=1). Electromechanical cardiac digital twin calibration and validation strategy was evaluated on Calibration to healthy physiological biomarkers. A biventricular multiscale electromechanical model was successfully calibrated to reproduce healthy physiological biomarkers, achieving a QRS duration of 89 ms and left ventricular ejection fraction of 51%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: